Ardent Health Partners (NYSE:ARDT) Receives "Overweight" Rating from Stephens

Ardent Health Partners (NYSE:ARDT - Get Free Report)'s stock had its "overweight" rating restated by equities research analysts at Stephens in a research note issued on Thursday,Benzinga reports. They presently have a $22.00 target price on the stock. Stephens' target price would indicate a potential upside of 46.28% from the company's current price.

Other equities research analysts have also recently issued research reports about the company. Royal Bank of Canada reissued an "outperform" rating and set a $23.00 target price on shares of Ardent Health Partners in a research note on Thursday, November 14th. Leerink Partners raised their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the stock an "outperform" rating in a research report on Tuesday, November 12th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $20.00 target price on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Bank of America cut shares of Ardent Health Partners from a "buy" rating to a "neutral" rating and dropped their price target for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. Finally, Morgan Stanley reduced their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 21st. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $21.36.

Ardent Health Partners Price Performance

Shares of ARDT traded up $0.38 during mid-day trading on Thursday, reaching $15.04. The stock had a trading volume of 842,317 shares, compared to its average volume of 407,308. Ardent Health Partners has a 52-week low of $13.55 and a 52-week high of $20.72. The business's fifty day moving average is $15.20 and its 200 day moving average is $16.84. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.31. The firm had revenue of $1.61 billion during the quarter, compared to analysts' expectations of $1.48 billion. On average, equities research analysts anticipate that Ardent Health Partners will post 1.23 earnings per share for the current year.

Hedge Funds Weigh In On Ardent Health Partners

Institutional investors and hedge funds have recently modified their holdings of the company. Ventas Inc. purchased a new stake in Ardent Health Partners during the 4th quarter worth about $159,570,000. Wellington Management Group LLP purchased a new stake in Ardent Health Partners during the third quarter worth approximately $28,724,000. Point72 Asset Management L.P. acquired a new position in Ardent Health Partners in the third quarter valued at approximately $27,428,000. Goldentree Asset Management LP acquired a new stake in Ardent Health Partners during the third quarter worth approximately $22,897,000. Finally, Franklin Resources Inc. purchased a new stake in shares of Ardent Health Partners during the 3rd quarter worth approximately $15,839,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.